Journal article · 1999

Setting bioequivalence requirements for drug development based on preclinical data: optimizing oral drug delivery systems

Elke Lipka, Gordon L. Amidon

Journal of Controlled Release, 62(1-2), 41–49 · Published 1 November 1999 · DOI 10.1016/s0168-3659(99)00022-x

View at the publisherCite this paper

In brief

“Setting bioequivalence requirements for drug development based on preclinical data: optimizing oral drug delivery systems” is a 1999 journal article by Elke Lipka and Gordon L. Amidon, published in Journal of Controlled Release. OpenAlex counts 81 citations as of 15 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
81
Most cited in
2015 (4)
Field-weighted impact
0.95
References
22
Authors
2

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Lipka, E., & Amidon, G. L. (1999). Setting bioequivalence requirements for drug development based on preclinical data: optimizing oral drug delivery systems. Journal of Controlled Release, 62(1-2), 41–49. https://doi.org/10.1016/s0168-3659(99)00022-x

MLA 9

Lipka, Elke, and Gordon L. Amidon. “Setting bioequivalence requirements for drug development based on preclinical data: optimizing oral drug delivery systems.” Journal of Controlled Release, vol. 62, no. 1-2, 1999, pp. 41–49. https://doi.org/10.1016/s0168-3659(99)00022-x.

Chicago

Lipka, Elke and Gordon L. Amidon. 1999. “Setting bioequivalence requirements for drug development based on preclinical data: optimizing oral drug delivery systems.” Journal of Controlled Release 62 (1-2): 41–49. https://doi.org/10.1016/s0168-3659(99)00022-x.

Harvard

Lipka, E. and Amidon, G. L. (1999) ‘Setting bioequivalence requirements for drug development based on preclinical data: optimizing oral drug delivery systems’, Journal of Controlled Release, 62(1-2), pp. 41–49. doi:10.1016/s0168-3659(99)00022-x.

IEEE

E. Lipka and G. L. Amidon, “Setting bioequivalence requirements for drug development based on preclinical data: optimizing oral drug delivery systems,” Journal of Controlled Release, vol. 62, no. 1-2, pp. 41–49, 1999, doi: 10.1016/s0168-3659(99)00022-x.

BibTeX

@article{lipka1999setting,
  title     = {{Setting bioequivalence requirements for drug development based on preclinical data: optimizing oral drug delivery systems}},
  author    = {Lipka, Elke and Amidon, Gordon L.},
  journal   = {Journal of Controlled Release},
  year      = {1999},
  volume    = {62},
  number    = {1-2},
  pages     = {41--49},
  doi       = {10.1016/s0168-3659(99)00022-x},
  url       = {https://doi.org/10.1016/s0168-3659(99)00022-x}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201544
201633
201722
201833
201911
202044
202144
202211
202422
202611

Its field-weighted citation impact is 0.95: it has been cited 0.95 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems

  • Biopharmaceutics Classification System
  • oral drug delivery
  • drug solubility
  • intestinal permeability
  • in vitro-in vivo correlation
  • dissolution testing
  • drug absorption

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Lipka, E., & Amidon, G. L. (1999). Setting bioequivalence requirements for drug development based on preclinical data: optimizing oral drug delivery systems. Journal of Controlled Release, 62(1-2), 41–49. https://doi.org/10.1016/s0168-3659(99)00022-x

How many times has this paper been cited?

81 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Elke Lipka, Gordon L. Amidon.

What is the DOI of this paper?

10.1016/s0168-3659(99)00022-x. The permanent link is https://doi.org/10.1016/s0168-3659(99)00022-x.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.